| pubmed-article:10204989 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10204989 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
| pubmed-article:10204989 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:10204989 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:10204989 | lifeskim:mentions | umls-concept:C1554963 | lld:lifeskim |
| pubmed-article:10204989 | lifeskim:mentions | umls-concept:C0101310 | lld:lifeskim |
| pubmed-article:10204989 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:10204989 | pubmed:dateCreated | 1999-6-7 | lld:pubmed |
| pubmed-article:10204989 | pubmed:abstractText | The use of smaller powder/liquid (P/L) ratio favours the handling and wetting of poly(methyl methacrylate) (PMMA) beads in bone cement formulations. In this paper a P/L ratio of 1.86 is tested to overcome adhesion problems found in hydroxypropyl methacrylate (HPMA) modified bone cements and the influence on bone cement characteristics was analysed. The reduction of the P/L ratio leads to higher temperature peaks and shorter setting times, whereas the residual monomer content increases slightly. Water uptake obeys the diffusion laws, and the introduction of a more hydrophilic monomer gives rise to an increase of this parameter, which does not present significant changes with modification of the P/L ratio. Polymerization shrinkage is slightly greater because of the introduction of higher proportions of monomer in the formulation. Mechanical properties are similar to those obtained with conventional P/L ratios. The analysis of scanning electron microscopy (SEM) reveals an improvement of the adhesion between phases with respect to P/L = 2 formulations. | lld:pubmed |
| pubmed-article:10204989 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10204989 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10204989 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10204989 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10204989 | pubmed:issn | 0142-9612 | lld:pubmed |
| pubmed-article:10204989 | pubmed:author | pubmed-author:GoñiII | lld:pubmed |
| pubmed-article:10204989 | pubmed:author | pubmed-author:GilF JFJ | lld:pubmed |
| pubmed-article:10204989 | pubmed:author | pubmed-author:PlanellJ AJA | lld:pubmed |
| pubmed-article:10204989 | pubmed:author | pubmed-author:PascualBB | lld:pubmed |
| pubmed-article:10204989 | pubmed:author | pubmed-author:GinebraM PMP | lld:pubmed |
| pubmed-article:10204989 | pubmed:author | pubmed-author:GurruchagaMM | lld:pubmed |
| pubmed-article:10204989 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10204989 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:10204989 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10204989 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10204989 | pubmed:pagination | 465-74 | lld:pubmed |
| pubmed-article:10204989 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:meshHeading | pubmed-meshheading:10204989... | lld:pubmed |
| pubmed-article:10204989 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10204989 | pubmed:articleTitle | Influence of the modification of P/L ratio on a new formulation of acrylic bone cement. | lld:pubmed |
| pubmed-article:10204989 | pubmed:affiliation | Dpto. Ciencia y Tecnología de Polímeros, Facultad de Química, UPV/EHU, San Sebastián, Spain. | lld:pubmed |
| pubmed-article:10204989 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10204989 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:10204989 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10204989 | lld:pubmed |
